Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Understanding differences between men and women with axial spondyloarthritis.
Journal: Seminars in arthritis and rheumatism
Published: January 28, 2020
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
Journal: Arthritis research & therapy
Published: November 05, 2019
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis.
Journal: Clinical rheumatology
Published: September 03, 2019
Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: May 26, 2018
Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data.
Journal: Journal of managed care & specialty pharmacy
Published: April 26, 2018
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.
Journal: Seminars in arthritis and rheumatism
Published: December 29, 2017
The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy.
Journal: Annals of the rheumatic diseases
Published: February 15, 2014
Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 26, 2013
A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: June 28, 2013
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study).
Journal: Annals of the rheumatic diseases
Published: September 16, 2011
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
Journal: The Journal of rheumatology
Published: February 17, 2007
Showing 1-12 of 12
Last Updated: 09/26/2026